arrow
J

Joaquim J. Ferreira

Universidade de Lisboa
H指数:79
被引数:2.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genetic variation in antidiabetic drug targets: associations with Parkinson’s disease risk and age at onset

抗糖尿病药物靶点的遗传变异:与帕金森病风险及发病年龄的关联

2026-05-280
OAAI
Substantia Nigra Neuromelanin Magnetic Resonance Imaging in LRRK2 Asymptomatic Carriers

黑质神经黑色素磁共振成像在LRRK2无症状携带者中的研究

2026-05-200
PRE
Genome-wide association study of copy number variations in Parkinson’s disease

帕金森病中全基因组拷贝数变异的关联研究

2026-04-200
OAAI
IDEA-FAST clinical study protocol: Identifying digital end-points of fatigue, sleep quality and daytime sleepiness in N = 2000

IDEA-FAST临床研究方案:识别2000名受试者中疲劳、睡眠质量和日间嗜睡的数字终点

2026-03-310
PRE
Early start of opicapone in Parkinson’s disease: evidence from a pooled analysis of phase 3 trials for sustained benefit in patients with recent onset of motor fluctuations

帕金森病中奥匹卡朋的早期开始:来自一项合并分析的证据,该分析基于3期试验,表明对于近期出现运动波动的患者具有持续获益。

2025-12-150
OAAI
Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK)

早期将金刚烷胺与左旋多巴疗法联合应用于帕金森病对运动障碍的影响:一项随机、安慰剂对照研究(PREMANDYSK)

2025-11-010
OAAI
Transforming Care Across Countries: Lessons from the Integrated Care Networks for Parkinson's Disease Study (iCARE-PD)

跨国护理转型:来自帕金森病综合护理网络研究(iCARE-PD)的经验

2025-11-010
OAAI
Advertising to Healthcare Professionals: Insights from Parkinson's Disease in the Movement Disorders Journal

向医疗专业人员发布广告:来自《运动障碍杂志》中帕金森病的见解

2025-10-300
OAAI